SavedAdd your journal

Journals / Medeniyet Medical Journal / 2022 / Cilt: 37 - Sayı: 1

Invasive Heart Rate Control as a Salvage Therapy in Amiodarone-induced Thyroid Storm

Amiodaron Kaynaklı Tiroid Fırtınasında Kurtarma Tedavisi Olarak İnvaziv Kalp Hızı Kontrolü

Oguzhan Ekrem TURAN
Emin Evren OZCAN
Mustafa DOGDUS
Resit Yigit YILANCIOGLU
Suleyman Cem ADIYAMAN
Pages
119–122
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Herein, we aimed to present atrioventricular node ablation as a salvage therapy in a patient with AIT who had AF-causing hemodynamic impairment, resistance to medical therapy, and cardioversion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Atrial fibrillation (AF) is the most common arrhythmia, and amiodarone is one of the most commonly used drugs for medical cardioversion of AF, which should be used carefully due to its toxic effects.
📊
Key Findings & Data:Amiodarone- induced thyrotoxicosis (AIT) may develop in amiodarone-treated patients.
💡
Conclusion & Impact:Herein, we aimed to present atrioventricular node ablation as a salvage therapy in a patient with AIT who had AF-causing hemodynamic impairment, resistance to medical therapy, and cardioversion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Atrial fibrillation (AF) is the most common arrhythmia, and amiodarone is one of the most commonly used drugs for medical cardioversion of AF, which should be used carefully due to its toxic effects. Amiodarone- induced thyrotoxicosis (AIT) may develop in amiodarone-treated patients. In contrast, the most common rhythm disturbance accompanying a thyroid storm is AF. This association may put both AF and thyrotoxicosis treatment into a vicious circle, leading to AI cardiomyopathy. Herein, we aimed to present atrioventricular node ablation as a salvage therapy in a patient with AIT who had AF-causing hemodynamic impairment, resistance to medical therapy, and cardioversion.

Özet

Atriyal fibrilasyon (AF) en sık görülen aritmidir ve amiodaron, AF'nin medikal kardiyoversiyonunda en sık kullanılan ve toksik etkileri nedeniyle dikkatli kullanılması gereken ilaçlardan biridir. Amiodaron ile tedavi edilen hastalarda amiodaron ile indüklenen tirotoksikoz (AİT) gelişebilir. Buna karşılık, bir tiroid fırtınasına eşlik eden en yaygın ritim bozukluğu AF'dir. Bu ilişki hem AF hem de tirotoksikoz tedavisini kısır bir döngüye sokabilir ve aritmi kaynaklı kardiyomiyopatiye yol açabilir. Burada hemodinamik bozukluğa neden olan, medikal tedaviye ve kardiyoversiyona dirençli AF’si olan bir AİT hastasında kurtarma tedavisi olarak atriyoventriküler düğüm ablasyonunu sunmayı amaçladık.

🔖

Cite This Article

TURAN, O. E., OZCAN, E. E., DOGDUS, M., YILANCIOGLU, R. Y., ADIYAMAN, S. C. (2022). Invasive Heart Rate Control as a Salvage Therapy in Amiodarone-induced Thyroid Storm. Medeniyet Medical Journal, Cilt: 37 - Sayı: 1, 119–122. https://ajindex.com/articles/579125

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893-962
  2. Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med. 2000;160:1741-8
  3. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984;101:28-34
  4. Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG. Amiodarone- induced thyroid dysfunction associated with cumulative dose. Pharmacoepidemiol Drug Saf. 2002;11:601-6
  5. Marrakchi S, Kanoun F, Idriss S, Kammoun I, Kachboura S. Arrhythmia and thyroid dysfunction. Herz. 2015;40(Suppl 2):101- 9
  6. Cardenas GA, Cabral JM, Leslie CA. Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies. Cleve Clin J Med. 2003;70:628-31
  7. Souza LVF, Campagnolo MT, Martins LCB, Scanavacca MI. Amiodarone-Induced Thyrotoxicosis - Literature Review & Clinical Update. Arq Bras Cardiol. 2021;117:1038-44
  8. Newman CM, Price A, Davies DW, Gray TA, Weetman AP. Amiodarone and the thyroid: A practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart. 1998;79:121-7
  9. Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone - associated thyroid dysfunction. Eur Thyroid J. 2018;7:55-66
  10. García Gil D, Escobar Jiménez L, Piñero Gálvez C, Girón González JA. Ablation of the hyperconducting atrioventricular node in a patient with thyrotoxicosis induced by amiodarone. Med Clin (Barc). 1995;105:238
  11. Marshall HJ, Griffith MJ. Ablation of the atrioventricular junction: technique, acute and long-term results in 115 consecutive patients. Europace. 1999;1:26-9
  12. Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J. 2021;42:4731-9.